Stereoselective Alcohol Silylation
FULL PAPER
(R)-1-(Naphth-1-yl)-2-(pyridin-2-yl)ethanol [(R)-24] (Table 5, entry 1):
According to GP 1, starting from rac-16 (99.7 mg, 0.400 mmol,
1.00 equiv), (SiR)-4a (49.1 mg, 0.240 mmol, 0.600 equiv, 93% ee), CuCl
(2.0 mg, 0.020 mmol, 0.050 equiv), L1d (13.9 mg, 0.0400 mmol,
0.100 equiv) and NaOtBu (1.9 mg, 0.020 mmol, 0.050 equiv) in toluene
(4.0 mL), silyl ether (SiS,S)-29a (102 mg, 57%, d.r. 84:16) and alcohol
(R)-24 (43 mg, 43%, 80% ee) were isolated as analytically pure materi-
als. (R)-24: M.p. 1148C (cyclohexane/tert-butyl methyl ether); Rf =0.17
(cyclohexane/tert-butyl methyl ether 1:1); [a]2D0 =+171 (c=0.320, CHCl3),
[a]52078 =+178, [a]52406 =+203, [a]42306 =+345, [a]23605 =+504; HPLC (Daicel
(w), 1100 (s), 1053 (s), 1032 (s), 1001 (s), 936 (m), 926 (s), 919 (s), 841
(s), 795 cmꢀ1 (s); HRMS (EI): m/z: calcd for C15H13NO [M+]: 223.0993,
found: 223.0997. (Z)-alkene: HPLC (Daicel Chiralcel OD-H, 208C, n-
heptane/iPrOH 90:10, flow rate 0.80 mLminꢀ1, l=230 nm): tR =10.9 min
(S enantiomer of Z-alkene), 13.9 min (R enantiomer of Z-alkene);
1H NMR (500 MHz, CDCl3): d=3.02 (dd, J=14.9, 3.5 Hz, 1H), 3.07 (dd,
J=15.1, 8.2 Hz, 1H), 5.01 (dddd, J=J=8.5, 3.2, 1.2 Hz, 1H), 5.57 (brs,
1H), 5.77 (dd, J=11.3, 9.1 Hz, 1H), 6.57 (brd, J=11.3 Hz, 1H), 7.13
(brd, J=7.9 Hz, 1H), 7.16–7.29 (m, 2H), 7.29–7.37 (m, 4H), 7.62 (ddd,
J=J=7.6, 1.9 Hz, 1H), 8.50 ppm (brd, J=5.0 Hz, 1H); 13C NMR
(125 MHz, CDCl3): d=43.3, 67.4, 121.8, 124.1, 127.2, 128.2, 128.3, 129.0,
131.1, 133.5, 136.8, 148.7, 159.9 ppm; HRMS (EI): m/z: calcd for
C15H15NO [M+]: 225.1154, found: 225.1150.
Chiralcel OD-H, 208C, n-heptane/iPrOH 90:10, flow rate 0.80 mLminꢀ1
,
l=230 nm): tR =18.6 min [(S)-24], 24.0 min [(R)-24]; 1H NMR (400 MHz,
CDCl3): d=3.25 (dd, J=15.3, 9.7 Hz, 1H), 3.35 (dd, J=15.4, 2.7 Hz,
1H), 5.85 (brs, 1H), 5.98 (dd, J=9.0, 2.7 Hz, 1H), 7.11 (brd, J=7.8 Hz,
1H), 7.22 (ddd, J=7.6, 5.0, 1.1 Hz, 1H), 7.47–7.54 (m, 3H), 7.63 (ddd,
J=J=7.6, 1.9 Hz, 1H), 7.77–7.81 (m, 2H), 7.88–7.91 (m, 1H), 8.12–8.16
(m, 1H), 8.60 ppm (ddd, J=5.0, 2.0, 1.0 Hz, 1H); 13C NMR (100 MHz,
CDCl3): d=44.9, 70.1, 121.9, 123.0, 123.3, 123.8, 125.4, 125.7, 126.0, 127.8,
129.0, 130.3, 133.8, 137.0, 139.5, 148.8, 160.0 ppm; IR (cuvette/CDCl3):
n˜ =3314 (s), 3062 (s), 2906 (w), 1599 (s), 1570 (s), 1512 (m), 1475 (s),
1438 (s), 1394 (m), 1359 (w), 1325 (w), 1281 (w), 1189 (s), 1102 (m), 1067
(w), 1003 (w), 891 (s), 883 (s), 805 cmꢀ1 (s); LRMS (EI): m/z: 249 [M+];
elemental analysis calcd (%) for C17H15NO (249.3): C 81.90, H 6.06, N
5.62; found: C 81.63, H 6.12, N 5.50.
(R)-1-Cyclohexyl-2-(pyridin-2-yl)ethanol [(R)-27] (Table 5, entry 4): Ac-
cording to GP 1, starting from rac-27 (82.1 mg, 0.400 mmol, 1.00 equiv),
(SiR)-4a (53.1 mg, 0.260 mmol, 0.650 equiv, 93% ee), CuCl (2.0 mg,
0.020 mmol, 0.050 equiv), L1d (13.9 mg, 0.0400 mmol, 0.100 equiv) and
NaOtBu (1.9 mg, 0.020 mmol, 0.050 equiv) in toluene (4.0 mL), silyl ether
(SiS,S)-32a (90 mg, 55%, d.r. 73:27) and alcohol (R)-27 (35 mg, 43%,
42% ee) were isolated as analytically pure materials. (R)-27: M.p. 358C
(cyclohexane/tert-butyl methyl ether); Rf =0.26 (cyclohexane/tert-butyl
20
546
methyl ether 1:1); [a]D20 =ꢀ5.82 (c=0.550, CHCl3), [a]25708 =ꢀ6.36, [a]
=
ꢀ7.64, [a]24306 =ꢀ18.5, [a]32605 =ꢀ50.4; HPLC (Daicel Chiralcel OD-H,
208C, n-heptane/iPrOH 98:2, flow rate 0.80 mLminꢀ1, l=230 nm): tR =
7.8 min [(R)-27], 8.7 min [(S)-27]; 1H NMR (400 MHz, CDCl3): d=1.05–
1.31 (m, 5H), 1.38–1.47 (m, 1H), 1.63–1.70 (m, 1H), 1.72–1.82 (m, 3H),
1.94 (m, 1H), 2.85 (dd, J=14.9, 9.2 Hz, 1H), 2.92 (dd, J=14.9, 2.6 Hz,
1H), 3.77 (ddd, J=9.2, 5.9, 2.6 Hz, 1H), 5.04 (brs, 1H), 7.11–7.16 (m,
2H), 7.61 (ddd, J=J=7.7, 1.9 Hz, 1H), 8.47 ppm (dd, J=5.6, 1.9 Hz,
1H); 13C NMR (100 MHz, CDCl3): d=26.3, 26.4, 26.7, 28.6, 29.1, 40.5,
43.6, 75.3, 121.5, 123.8, 136.8, 148.6, 160.9 ppm; IR (cuvette/CDCl3): n˜ =
3333 (s), 3142 (w), 3089 (w), 3076 (w), 3018 (w), 2929 (s), 2854 (s), 1597
(s), 1570 (m), 1475 (s), 1450 (s), 1437 (s), 1345 (w), 1312 (w), 1277 (m),
1262 (m), 1228 (m), 1193 (m), 1175 (m), 1150 (m), 1131 (m), 1102 (m),
1051 (m), 1034 (s), 1002 (m), 990 (m), 900 (s), 841 (m), 809 cmꢀ1 (m);
LRMS (CI/NH3): m/z: 206 [M+H+]; elemental analysis calcd (%) for
C13H19NO (205.3): C 76.06, H 9.33, N 6.82; found: C 75.95, H 9.50, N
6.64.
ACHTUNGTRENNUNG(R,E)-4-Phenyl-1-(pyridin-2-yl)but-3-en-2-ol [(R)-25] (Table 5, entry 2):
According to GP 1, starting from rac-25 (90.1 mg, 0.400 mmol,
1.00 equiv), (SiR)-4a (49.1 mg, 0.240 mmol, 0.600 equiv, 93% ee), CuCl
(2.0 mg, 0.020 mmol, 0.050 equiv), L1d (13.9 mg, 0.0400 mmol,
0.100 equiv) and NaOtBu (1.9 mg, 0.020 mmol, 0.050 equiv) in toluene
(4.0 mL), silyl ether (SiS,S)-30a (99 mg, 56%, d.r. 87:13) and alcohol (R)-
25 (38 mg, 43%, 74% ee) were isolated as analytically pure materials.
(R)-25: Rf =0.24 (cyclohexane/tert-butyl methyl ether 1:2); [a]2D0 =ꢀ67.5
20
365
(c=0.440, CHCl3), [a]25708 =ꢀ71.4, [a]25046 =ꢀ82.5, [a]42306 =ꢀ163, [a]
=
ꢀ326; HPLC (Daicel Chiralcel OD-H, 208C, n-heptane/iPrOH 90:10,
flow rate 0.80 mLminꢀ1
, l=230 nm): tR =17.9 min [(R)-25], 20.5 min
[(S)-25]; 1H NMR (500 MHz, CDCl3): d=3.03 (dd, J=15.5, 8.5 Hz, 1H),
3.10 (dd, J=15.2, 3.5 Hz, 1H), 4.78 (dddd, J=8.5, 6.0, 3.5, 1.3 Hz, 1H),
5.48 (brs, 1H), 6.31 (dd, J=15.7, 5.8 Hz, 1H), 6.68 (dd, J=15.7, 1.6 Hz,
1H), 7.16–7.20 (m, 2H), 7.20–7.24 (m, 1H), 7.28–7.32 (m, 2H), 7.36–7.39
(m, 2H), 7.64 (ddd, J=J=7.6, 1.9 Hz, 1H), 8.52 ppm (ddd, J=4.7, 1.9,
1.0 Hz, 1H); 13C NMR (125 MHz, CDCl3): d=43.6, 71.8, 121.8, 123.9,
126.6, 127.5, 128.6, 130.0, 131.7, 136.9, 137.1, 148.7, 159.7 ppm; IR (cuv-
ette/CDCl3): n˜ =3306 (s), 3143 (w), 3084 (m), 3063 (m), 3028 (s), 2908
(m), 1596 (s), 1570 (s), 1494 (s), 1475 (s), 1438 (s), 1326 (w), 1307 (w),
1188 (m), 1150 (m), 1101 (m), 1088 (m), 1069 (s), 1050 (s), 1029 (s), 1001
(s), 968 (s), 921 (s), 904 (m), 892 (m), 888 (m), 809 cmꢀ1 (s); LRMS (EI):
m/z: 225 [M+]; elemental analysis calcd (%) for C15H15NO (225.3): C
79.97, H 6.71, N 6.22; found: C 79.82, H 6.66, N 6.24.
(S)-1-(Pyridin-2-yl)propan-2-ol [(S)-28] (Table 5, entry 5): According to
GP 1, starting from rac-28 (54.9 mg, 0.400 mmol, 1.00 equiv), (SiR)-4a
(49.1 mg, 0.240 mmol, 0.600 equiv, 93% ee), CuCl (2.0 mg, 0.020 mmol,
0.050 equiv), L1d (13.9 mg, 0.0400 mmol, 0.100 equiv) and NaOtBu
(1.9 mg, 0.020 mmol, 0.050 equiv) in toluene (4.0 mL), silyl ether (SiS,R)-
33a (77 mg, 57%, d.r. 76:24) and alcohol (R)-27 (23 mg, 42%, 73% ee)
were isolated as analytically pure materials. (S)-28: Rf =0.25 (CH2Cl2/
20
546
MeOH 97:3); [a]D20 =+5.71 (c=0.350, CHCl3), [a]25708 =+6.29, [a]
=
+5.15, [a]24306 =ꢀ3.43, [a]32605 =ꢀ43.7; HPLC (Daicel Chiralcel AD-H,
208C, n-heptane/iPrOH 98:2, flow rate 0.80 mLminꢀ1, l=230 nm): tR =
34.9 min [(S)-28], 43.3 min [(R)-28]; 1H NMR (500 MHz, CDCl3): d=
1.26 (d, J=6.3 Hz, 3H), 2.84 (dd, J=15.0, 8.4 Hz, 1H), 2.89 (dd, J=15.0,
3.3 Hz, 1H), 4.23 (dqd, J=8.4, 6.3, 3.3 Hz, 1H), 5.08 (brs, 1H), 7.12–7.17
(m, 2H), 7.62 (ddd, J=J=7.7, 1.9 Hz, 1H), 8.49 ppm (ddd, J=4.9, 1.8,
0.9 Hz, 1H); 13C NMR (125 MHz, CDCl3): d=32.1, 45.0, 67.2, 121.6,
123.7, 136.8, 148.7, 160.3 ppm; IR (cuvette/CDCl3): n˜ =3343 (s), 3142 (w),
3087 (w), 3018 (w), 2974 (s), 2932 (m), 2903 (m), 1596 (s), 1570 (s), 1476
(s), 1438 (s), 1374 (w), 1331 (w), 1283 (w), 1198 (m), 1150 (m), 1128 (m),
1100 (w), 1078 (m), 1052 (s), 1027 (m), 1001 (m), 937 (s), 930 (s), 840 (s),
795 cmꢀ1 (s); HRMS (ESI): m/z: calcd for C8H11NONa [M+Na+]:
160.0733, found: 160.0729.
(R)-4-Phenyl-1-(pyridin-2-yl)but-3-in-2-ol [(R)-26] (Table 5, entry 3): Ac-
cording to GP 1, starting from rac-26 (89.3 mg, 0.400 mmol, 1.00 equiv),
(SiR)-4a (53.1 mg, 0.260 mmol, 0.650 equiv, 93% ee), CuCl (2.0 mg,
0.020 mmol, 0.050 equiv), L1d (13.9 mg, 0.0400 mmol, 0.100 equiv) and
NaOtBu (1.9 mg, 0.020 mmol, 0.050 equiv) in toluene (4.0 mL), silyl ether
(SiS,S)-31a (87 mg, 51%, d.r. 74:26) and alcohol (R)-26 (38 mg, 31%,
89% ee) were isolated as yellowish oils. Silyl ether (SiS,S)-31a was conta-
minated with 7% the silyl ether of Z-alkene [Z/E 93:7, d.r. (Z isomer)
90:10]; (R)-26 contained 21% of (Z)-alkene (57% ee) as determined by
1H NMR spectroscopy. (R)-26: Rf =0.29 (cyclohexane/tert-butyl methyl
ether 1:2); [a]D20 =ꢀ3.94 (c=0.330, CHCl3), [a]25708 =ꢀ5.15, [a]52406 =ꢀ6.67,
[a]24036 =ꢀ20.6; HPLC (Daicel Chiralcel OD-H, 208C, n-heptane/iPrOH
90:10, flow rate 0.80 mLminꢀ1
, l=230 nm): tR =15.9 min [(R)-26],
(S)-1-Phenyl-2-(6-methylpyridin-2-yl)ethanol [(S)-34] (Table 6, entry 1):
According to GP 1, starting from rac-34 (85.3 mg, 0.400 mmol,
1.00 equiv), (SiS)-4a (49.1 mg, 0.240 mmol, 0.600 equiv, 98% ee), CuCl
(2.0 mg, 0.020 mmol, 0.050 equiv), L1d (13.9 mg, 0.0400 mmol,
0.100 equiv) and NaOtBu (1.9 mg, 0.020 mmol, 0.050 equiv) in toluene
(4.0 mL), silyl ether (SiR,R)-41a (94 mg, 57%, d.r. 77:23) and alcohol (S)-
34 (27 mg, 32%, 89% ee) were isolated as analytically pure materials.
(S)-34: M.p. 378C (tert-butyl methyl ether); Rf =0.26 (cyclohexane/tert-
butyl methyl ether 1:1); [a]2D0 =ꢀ30.9 (c=0.555, CHCl3), [a]25708 =ꢀ32.2,
24.4 min [(S)-26]; 1H NMR (500 MHz, CDCl3): d=3.24 (dd, J=15.1,
7.2 Hz, 1H), 3.30 (dd, J=15.1, 3.8 Hz, 1H), 5.08 (dd, J=7.2, 3.8 Hz, 1H),
5.57 (brs, 1H), 7.16–7.29 (m, 5H), 7.29–7.37 (m, 2H), 7.67 (ddd, J=J=
7.8, 1.9 Hz, 1H), 8.52 ppm (brd, J=4.7 Hz, 1H); 13C NMR (125 MHz,
CDCl3): d=43.6, 62.3, 84.6, 89.7, 122.0, 122.9, 123.9, 128.3, 128.3, 131.8,
137.0, 148.7, 159.0 ppm; IR (cuvette/CDCl3): n˜ =3305 (s), 3084 (m), 3063
(m), 3020 (s), 2977 (s), 2930 (m), 1597 (s), 1571 (s), 1491 (s), 1476 (s),
1438 (s), 1389 (w), 1367 (w), 1325 (w), 1283 (w), 1235 (w), 1200 (m), 1151
Chem. Eur. J. 2008, 14, 11512 – 11528
ꢂ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
11525